###begin article-title 0
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome
###end article-title 0
###begin p 1
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large</italic>
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myd</italic>
###xml 239 244 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 585 590 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 694 699 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 870 875 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 292 299 <span type="species:ncbi:9606">patient</span>
###xml 537 544 <span type="species:ncbi:9606">patient</span>
###xml 652 658 <span type="species:ncbi:9606">humans</span>
Intragenic homozygous deletions in the Large gene are associated with a severe neuromuscular phenotype in the myodystrophy (myd) mouse. These mutations result in a virtual lack of glycosylation of alpha-dystroglycan. Compound heterozygous LARGE mutations have been reported in a single human patient, manifesting with mild congenital muscular dystrophy (CMD) and severe mental retardation. These mutations are likely to retain some residual LARGE glycosyltransferase activity as indicated by residual alpha-dystroglycan glycosylation in patient cells. We hypothesized that more severe LARGE mutations are associated with a more severe CMD phenotype in humans. Here we report a 63-kb intragenic LARGE deletion in a family with Walker-Warburg syndrome (WWS), which is characterized by CMD, and severe structural brain and eye malformations. This finding demonstrates that LARGE gene mutations can give rise to a wide clinical spectrum, similar as for other genes that have a role in the post-translational modification of the alpha-dystroglycan protein.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s00439-007-0362-y) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 378 383 374 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2005a</xref>
###xml 650 651 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 859 863 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2006</xref>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Abnormal O-linked glycosylation of alpha-dystroglycan is the common pathogenic mechanism in a group of patients with a clinical spectrum ranging from severe congenital muscular dystrophy (CMD), structural brain, and eye abnormalities [Walker-Warburg syndrome (WWS), MIM 236670] to a relative mild form of limb-girdle muscular dystrophy (LGMD2I, MIM 607155) (van Reeuwijk et al. 2005a). In muscle tissue, alpha-dystroglycan acts as a bridge between the extracellular matrix laminin and the actin cytoskeleton through the transmembranal beta-dystroglycan. The interaction of alpha-dystroglycan with the extracellular matrix proteins is mediated by its O-glycosylated moiety. Mature alpha-dystroglycan in brain binds to laminin and neurexin, which is important for neuronal migration in the neocortex and the integrity of the glia limitans (Barresi and Campbell 2006).
###end p 5
###begin p 6
###xml 135 139 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCMD</italic>
###xml 141 145 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FKRP</italic>
###xml 147 152 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 154 161 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMGnT1</italic>
###xml 163 168 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT1</italic>
###xml 174 179 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT2</italic>
###xml 188 192 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2006</xref>
###xml 216 220 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCMD</italic>
###xml 222 226 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FKRP</italic>
###xml 228 233 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT1</italic>
###xml 239 244 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT2</italic>
###xml 735 739 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2006</xref>
###xml 756 760 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2006</xref>
###xml 782 786 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">2006</xref>
###xml 808 813 800 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2005a</xref>
###xml 895 900 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
Mutations that result in hypoglycosylation of alpha-dystroglycan have been identified in known and putative glycosyltransferase genes: FCMD, FKRP, LARGE, POMGnT1, POMT1, and POMT2 (Freeze 2006). Four of these genes, FCMD, FKRP, POMT1, and POMT2, have been implicated in WWS. These genes explain approximately one-third of the WWS patients in our cohort. Interestingly, different mutations in these genes are known to cause phenotypic variability ranging from WWS to limb-girdle muscular dystrophy. Thus, it appears that mutations in genes that affect the glycosylation of alpha-dystroglycan can give rise to a number of related disorders, thereby blurring the boundaries between these clinically defined 'dystroglycanopathies' (Freeze 2006; Mercuri et al. 2006; van Reeuwijk et al. 2006; van Reeuwijk et al. 2005a). Here, we have investigated whether allelic variability does also occur for the LARGE gene.
###end p 6
###begin p 7
###xml 171 176 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 309 313 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2004</xref>
###xml 329 334 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 768 772 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2003</xref>
###xml 790 793 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myd</italic>
###xml 836 841 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large</italic>
###xml 848 851 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">myd</sup>
###xml 970 974 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2001</xref>
###xml 991 995 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2003</xref>
###xml 1012 1016 1004 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2002</xref>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 361 368 <span type="species:ncbi:9606">patient</span>
###xml 450 457 <span type="species:ncbi:9606">patient</span>
###xml 648 655 <span type="species:ncbi:9606">patient</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
The LARGE protein is a putative glycosyltransferase, required for addition of as yet unknown glycans onto the alpha-dystroglycan protein. Interestingly, overexpression of LARGE can by-pass the glycosylation defects in cells from patients with WWS or muscle-eye-brain disease (MEB, MIM 253280) (Barresi et al. 2004). Mutations in LARGE have been identified in a patient with relatively mild CMD and severe mental retardation (MDC1D: MIM 608840). This patient is compound heterozygous for p.E509K and p.C667fs. These mutations do not seem to abolish the activity of the LARGE protein completely, as Western blot analysis of skeletal muscle from this patient indicates residual functional glycosylation and laminin binding activity for alpha-dystroglycan (Longman et al. 2003). Interestingly, myd mice that carry a spontaneous deletion in Large (Largemyd), resemble the more severe clinical Fukuyama congenital muscular dystrophy (FCMD, MIM 253800), and MEB (Grewal et al. 2001; Longman et al. 2003; Michele et al. 2002).
###end p 7
###begin p 8
###xml 139 144 139 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2005b</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">a</xref>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 238 245 <span type="species:ncbi:9606">patient</span>
Based on linkage studies we expect that there are multiple other genes that give rise to a WWS phenotype when mutated (van Reeuwijk et al. 2005b, and unpublished data). Here we report a homozygous 63-kb intragenic deletion in LARGE, in a patient who had familial classical WWS characteristics. This result establishes LARGE as the fifth WWS gene.
###end p 8
###begin title 9
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 9
###begin title 10
Case reports
###end title 10
###begin p 11
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1160 1166 1160 1166 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1209 1210 1209 1210 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1211 1212 1211 1212 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1229 1230 1229 1230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1231 1232 1231 1232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1392 1393 1392 1393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1419 1420 1419 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1422 1423 1422 1423 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1441 1442 1441 1442 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1444 1445 1444 1445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1664 1665 1664 1665 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1666 1667 1666 1667 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1166 1668 1166 1668 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Phenotype and brain CT scans of patient 1 (<bold>a</bold>&#8211;<bold>c</bold>) and patient 2 (<bold>d</bold>&#8211;<bold>f</bold>). Patient 1 showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs, and valgus deformity of the feet (<bold>a</bold>). Brain CT of patient 1 (<bold>b</bold>, <bold>c</bold>), and patient 2 (<bold>e</bold>, <bold>f</bold>) show absence of the inferior cerebellar vermis, a hypoplastic cerebellum, and marked dilatation of the lateral ventricles. Patient 2 also shows severe hydrocephalus with wide fontanel and separated sutures and cysts (<bold>d</bold>&#8211;<bold>f</bold>)</p>
###xml 1166 1668 1166 1668 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Phenotype and brain CT scans of patient 1 (<bold>a</bold>&#8211;<bold>c</bold>) and patient 2 (<bold>d</bold>&#8211;<bold>f</bold>). Patient 1 showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs, and valgus deformity of the feet (<bold>a</bold>). Brain CT of patient 1 (<bold>b</bold>, <bold>c</bold>), and patient 2 (<bold>e</bold>, <bold>f</bold>) show absence of the inferior cerebellar vermis, a hypoplastic cerebellum, and marked dilatation of the lateral ventricles. Patient 2 also shows severe hydrocephalus with wide fontanel and separated sutures and cysts (<bold>d</bold>&#8211;<bold>f</bold>)</p></caption>
###xml 1668 1668 1668 1668 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2007_362_Fig1_HTML" id="MO1"/>
###xml 1160 1668 1160 1668 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="12">Phenotype and brain CT scans of patient 1 (<bold>a</bold>&#8211;<bold>c</bold>) and patient 2 (<bold>d</bold>&#8211;<bold>f</bold>). Patient 1 showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs, and valgus deformity of the feet (<bold>a</bold>). Brain CT of patient 1 (<bold>b</bold>, <bold>c</bold>), and patient 2 (<bold>e</bold>, <bold>f</bold>) show absence of the inferior cerebellar vermis, a hypoplastic cerebellum, and marked dilatation of the lateral ventricles. Patient 2 also shows severe hydrocephalus with wide fontanel and separated sutures and cysts (<bold>d</bold>&#8211;<bold>f</bold>)</p></caption><graphic position="anchor" xlink:href="439_2007_362_Fig1_HTML" id="MO1"/></fig>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 1198 1205 <span type="species:ncbi:9606">patient</span>
###xml 1218 1225 <span type="species:ncbi:9606">patient</span>
###xml 1235 1242 <span type="species:ncbi:9606">Patient</span>
###xml 1408 1415 <span type="species:ncbi:9606">patient</span>
###xml 1430 1437 <span type="species:ncbi:9606">patient</span>
###xml 1570 1577 <span type="species:ncbi:9606">Patient</span>
Patient 1 is a Saudi female and was delivered normally at term. Parents were second-degree cousins. Mother was gravida 5 para 4 with uneventful pregnancy, no polyhydramnios, or reduced fetal movements. Apgar scores were 5 and 8 at 1 and 5 min, respectively. Birth weight 2,880 g (25th centile), length 50 cm (50th centile), head circumference 37 cm (>90th centile). Physical examination (Fig. 1a) showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs and valgus deformity of the feet. She had poor respiratory effort. Anterior fontanel was wide with separated sutures, deep tendon reflexes were absent, and sensations were intact. Ophthalmic examination revealed dense bilateral congenital cataract in the left eye and mild lens opacity with pigmentary degeneration of the retina and optic atrophy in the right eye. She was discharged from the Neonatal Intensive Care Unit (NICU) at the age of 3 months. At the age of 4 months her weight was on the 25th centile, length 10th centile and head circumference above 95th centile. She was developmentally delayed and blind. She died at the age of 6 months. Fig. 1Phenotype and brain CT scans of patient 1 (a-c) and patient 2 (d-f). Patient 1 showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs, and valgus deformity of the feet (a). Brain CT of patient 1 (b, c), and patient 2 (e, f) show absence of the inferior cerebellar vermis, a hypoplastic cerebellum, and marked dilatation of the lateral ventricles. Patient 2 also shows severe hydrocephalus with wide fontanel and separated sutures and cysts (d-f)
###end p 11
###begin p 12
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 65 66 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 253 254 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 275 276 275 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 498 499 498 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 500 501 500 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
###xml 52 59 <span type="species:ncbi:9606">patient</span>
###xml 69 76 <span type="species:ncbi:9606">Patient</span>
###xml 242 249 <span type="species:ncbi:9606">patient</span>
###xml 264 271 <span type="species:ncbi:9606">patient</span>
###xml 404 411 <span type="species:ncbi:9606">Patient</span>
Phenotype and brain CT scans of patient 1 (a-c) and patient 2 (d-f). Patient 1 showed no dysmorphic features, severe generalized hypotonia with very little spontaneous movements of the limbs, and valgus deformity of the feet (a). Brain CT of patient 1 (b, c), and patient 2 (e, f) show absence of the inferior cerebellar vermis, a hypoplastic cerebellum, and marked dilatation of the lateral ventricles. Patient 2 also shows severe hydrocephalus with wide fontanel and separated sutures and cysts (d-f)
###end p 12
###begin p 13
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
Laboratory investigations showed remarkably high-creatine kinase (CK) of 28,600 U/l (N 24-170) on the third day of life and 1,086 U/l at the age of 1 month. Liver function tests (LFT), metabolic screen, TORCH panel for congenital infections were all normal. Chromosome analysis was normal female karyotype. Brain CT (Fig. 1b, c) showed marked dilatation of the lateral ventricles with moderate dilatation of the third ventricle, there was a striking decrease in attenuation surrounding the dilated ventricles, the inferior cerebellar vermis was absent, and the cerebellum was hypoplastic. EEG showed frequent right tempro-occipital burst of sharp and slow activity. Brain auditory evoked responses (BAER) using monoaural click stimulation was normal. Muscle biopsy showed features of dystrophy. A diagnosis of WWS was made based on the CNS, eye, and muscle involvements. No DNA or tissue sample was available for this study.
###end p 13
###begin p 14
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 939 940 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 36 43 <span type="species:ncbi:9606">patient</span>
Patient 2 is the younger sibling of patient 1. Antenatal ultrasound showed hydrocephalus and he was delivered by emergency cesarean section. Apgar scores were 6 and 9 at 1 and 5 min, respectively. Physical examination (Fig. 1d) showed severe hydrocephalus with wide fontanel and separated sutures, and head circumference was 46 cm, above the 97th centile. He had generalized hypotonia, absent deep tendon reflexes but no dysmorphic features. Ophthalmic examination showed bilateral leukocornia, retinal dysplasia, and posterior synechia. Brain CT (Fig. 1e, f) revealed severe hydrocephalus with Dandy-Walker malformation and minimal brain tissue, absent inferior cerebellar vermis and hypoplastic cerebellum. CK was elevated at 18,000 U/l (N 24-195). Lactate dehydrogenase was high at 1,690 U/l (N 230-460). Liver enzymes were mildly elevated, alanine aminotransferase (ALT) 53 U/l (N 10-50), and aspartate aminotransferase (AST) 142 U/l (N 10-45 U/l). Tandem mass spectrometry (MS) for metabolic screen was unremarkable; TORCH for congenital infections was negative. Chromosome analysis showed normal male karyotype. Muscle biopsy was done at the age of 11 days and revealed dystrophic features in the form of myofiber necrosis, basophilic fibers and interstitial endomysial, and perimysial fibrosis. There was no specific fiber type atrophy or grouping. A limited number of immunostains were done and included dystrophin and alpha-sarcoglycan. Both immunostains were normally positive.
###end p 14
###begin p 15
A ventriculoperitoneal shunt was inserted. He was weaned off the ventilatory support and died at the age of 2 months. A diagnosis of WWS was made.
###end p 15
###begin p 16
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 140 146 140 146 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 217 229 217 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Open symbols</italic>
###xml 275 294 275 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid black symbols</italic>
###xml 146 320 146 320 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="17">Family pedigree. Females are represented by <italic>circles</italic>, males by <italic>squares</italic>. <italic>Open symbols</italic> represent the unaffected family members, the <italic>solid black symbols</italic> the WWS affected siblings</p>
###xml 146 320 146 320 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="17">Family pedigree. Females are represented by <italic>circles</italic>, males by <italic>squares</italic>. <italic>Open symbols</italic> represent the unaffected family members, the <italic>solid black symbols</italic> the WWS affected siblings</p></caption>
###xml 320 320 320 320 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2007_362_Fig2_HTML" id="MO2"/>
###xml 140 320 140 320 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="17">Family pedigree. Females are represented by <italic>circles</italic>, males by <italic>squares</italic>. <italic>Open symbols</italic> represent the unaffected family members, the <italic>solid black symbols</italic> the WWS affected siblings</p></caption><graphic position="anchor" xlink:href="439_2007_362_Fig2_HTML" id="MO2"/></fig>
Nine other siblings were born healthy and DNA was obtained from seven, as well as the parents. A pedigree of the family is given in Fig. 2. Fig. 2Family pedigree. Females are represented by circles, males by squares. Open symbols represent the unaffected family members, the solid black symbols the WWS affected siblings
###end p 16
###begin p 17
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 71 83 71 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Open symbols</italic>
###xml 129 148 129 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid black symbols</italic>
Family pedigree. Females are represented by circles, males by squares. Open symbols represent the unaffected family members, the solid black symbols the WWS affected siblings
###end p 17
###begin title 18
Linkage analysis and mutation analysis
###end title 18
###begin p 19
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
DNA was extracted from blood lymphocytes using standard procedures. Linkage to the LARGE locus was assessed by genotyping two microsatellite markers flanking the gene (D22S281 and D22S529) and two intragenic markers (D22S1162 and D22S1172).
###end p 19
###begin p 20
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
Primer3 () was used to design specific primers (supplementary Table 1) for PCR amplification and direct sequencing of the 14 coding exons (including intron-exon boundaries) of LARGE (NM_004737.3).
###end p 20
###begin title 21
Copy number detection
###end title 21
###begin p 22
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2000</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2002</xref>
Copy number detection of the 16 LARGE exons was performed by Multiplex Amplifiable Probe Hybridization (MAPH). A series of probes for the 16 LARGE exons were generated by PCR and cloned into pZERO (Invitrogen, Carlsbad, CA, USA). MAPH was carried out and probe ratios analyzed essentially as previously described (Armour et al. 2000; Hollox et al. 2002).
###end p 22
###begin p 23
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
Multiplex Ligation-dependent Probe Amplification (MLPA) was used to further restrict the deletion breakpoints. MLPA probes were designed within exons 8-11 and intron 8 and 10 of the LARGE gene (supplementary Table 2). A protocol for designing these probes and hybridization, ligation, and amplification of these probes is provided by MRC-Holland (). Product separation was performed using capillary electrophoresis on an ABI 3730 or 3100 sequencer (Applied Biosystems, Foster City, CA). For quantitative analysis, trace data were retrieved using Genemapper software following the manufacturer's protocol (Applied Biosystems).
###end p 23
###begin title 24
Long-range PCR method and sequence analysis of breakpoints
###end title 24
###begin p 25
The breakpoint-spanning region was amplified by long-range PCR amplification with specific primers (supplementary Table 3) and LA TaqTM (TaKaRa Bio Inc., Shiga, Japan) using PCR conditions recommended by the manufacturer. We then used different combinations of primers to further restrict the breakpoint-spanning region and identified the breakpoint by direct sequencing.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
Linkage to the LARGE locus and mutation analysis
###end title 27
###begin p 28
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
We hypothesized that severe LARGE mutations give rise to WWS. To assess this hypothesis we selected intragenic and LARGE flanking genetic markers to test for homozygosity in 30 WWS patients from consanguineous parents. Seven patients from six unrelated families showed homozygosity for at least two intragenic markers (D22S1162 and D22S1172) and one marker (D22S281 or D22S529) in close proximity of LARGE.
###end p 28
###begin p 29
###xml 370 378 <span type="species:ncbi:9606">patients</span>
We performed mutation analysis for all 14 coding exons including intron-exon boundaries by direct sequence analysis. No mutations were found. However, difficulties during the PCR amplification of some of the exons suggested a possible deletion of these exons in one of the families. Two affected siblings in this family manifest typical WWS features as described in the patients and methods section.
###end p 29
###begin title 30
Identification of a submicroscopic deletion by copy number detection
###end title 30
###begin p 31
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 408 414 408 414 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">diamonds</italic>
###xml 593 617 593 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles, triangles</italic>
###xml 623 630 623 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 716 739 716 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Open circles, triangles</italic>
###xml 745 752 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 414 779 414 779 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">MLPA analysis, showing a deletion of two exonic probes (EX9 and EX10) and two flanking intronic probes (IN8-2 and IN10) in the patient (<italic>diamonds</italic>), and in the unaffected carriers (<italic>black circles, triangles</italic>, and <italic>squares</italic>). No intronic probes were tested for the patient due to limited availability of DNA. <italic>Open circles, triangles</italic>, and <italic>squares</italic> depict control individuals</p>
###xml 414 779 414 779 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">MLPA analysis, showing a deletion of two exonic probes (EX9 and EX10) and two flanking intronic probes (IN8-2 and IN10) in the patient (<italic>diamonds</italic>), and in the unaffected carriers (<italic>black circles, triangles</italic>, and <italic>squares</italic>). No intronic probes were tested for the patient due to limited availability of DNA. <italic>Open circles, triangles</italic>, and <italic>squares</italic> depict control individuals</p></caption>
###xml 779 779 779 779 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2007_362_Fig3_HTML" id="MO3"/>
###xml 408 779 408 779 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="32">MLPA analysis, showing a deletion of two exonic probes (EX9 and EX10) and two flanking intronic probes (IN8-2 and IN10) in the patient (<italic>diamonds</italic>), and in the unaffected carriers (<italic>black circles, triangles</italic>, and <italic>squares</italic>). No intronic probes were tested for the patient due to limited availability of DNA. <italic>Open circles, triangles</italic>, and <italic>squares</italic> depict control individuals</p></caption><graphic position="anchor" xlink:href="439_2007_362_Fig3_HTML" id="MO3"/></fig>
###xml 161 168 <span type="species:ncbi:9606">patient</span>
###xml 541 548 <span type="species:ncbi:9606">patient</span>
###xml 672 679 <span type="species:ncbi:9606">patient</span>
Using MAPH we screened all 16 exons for copy number changes. Exon 9 and 10 showed copy number changes in one family, indicative for a deletion of these exons in patient 2 (homozygous) and in the parents (hemizygous). This result was confirmed by MLPA analysis of probes specific to these exons and surrounding intronic sequences, which also further defined the size of the deletion to 61.1-66.6 kb (Fig. 3). Fig. 3MLPA analysis, showing a deletion of two exonic probes (EX9 and EX10) and two flanking intronic probes (IN8-2 and IN10) in the patient (diamonds), and in the unaffected carriers (black circles, triangles, and squares). No intronic probes were tested for the patient due to limited availability of DNA. Open circles, triangles, and squares depict control individuals
###end p 31
###begin p 32
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">diamonds</italic>
###xml 179 203 179 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black circles, triangles</italic>
###xml 209 216 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 302 325 302 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Open circles, triangles</italic>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">squares</italic>
###xml 127 134 <span type="species:ncbi:9606">patient</span>
###xml 258 265 <span type="species:ncbi:9606">patient</span>
MLPA analysis, showing a deletion of two exonic probes (EX9 and EX10) and two flanking intronic probes (IN8-2 and IN10) in the patient (diamonds), and in the unaffected carriers (black circles, triangles, and squares). No intronic probes were tested for the patient due to limited availability of DNA. Open circles, triangles, and squares depict control individuals
###end p 32
###begin title 33
Analysis of breakpoints
###end title 33
###begin p 34
###xml 220 221 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 861 866 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 952 957 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large</italic>
###xml 970 973 958 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myd</italic>
###xml 996 1000 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2005</xref>
###xml 1003 1009 991 997 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1031 1036 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 1071 1072 1059 1060 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1096 1097 1084 1085 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1130 1141 1118 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black boxes</italic>
###xml 1174 1184 1162 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 1379 1380 1367 1368 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1009 1381 997 1369 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Schematic overview of <italic>LARGE</italic> exons 8&#8211;11 of wild-type sequence (<bold>a</bold>) and patient sequence (<bold>b</bold>), showing the exons depicted by <italic>black boxes</italic> and the MLPA probes depicted by <italic>black bars</italic>. MLPA analysis revealed deletion of four MLPA probes (IN8-2, EX9, EX10, and IN10). Sequence analysis of the breakpoint region in the patient revealed the exact position of the 63.1&#160;kb deletion (<bold>c</bold>)</p>
###xml 1009 1381 997 1369 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Schematic overview of <italic>LARGE</italic> exons 8&#8211;11 of wild-type sequence (<bold>a</bold>) and patient sequence (<bold>b</bold>), showing the exons depicted by <italic>black boxes</italic> and the MLPA probes depicted by <italic>black bars</italic>. MLPA analysis revealed deletion of four MLPA probes (IN8-2, EX9, EX10, and IN10). Sequence analysis of the breakpoint region in the patient revealed the exact position of the 63.1&#160;kb deletion (<bold>c</bold>)</p></caption>
###xml 1381 1381 1369 1369 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="439_2007_362_Fig4_HTML" id="MO4"/>
###xml 1003 1381 991 1369 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="35">Schematic overview of <italic>LARGE</italic> exons 8&#8211;11 of wild-type sequence (<bold>a</bold>) and patient sequence (<bold>b</bold>), showing the exons depicted by <italic>black boxes</italic> and the MLPA probes depicted by <italic>black bars</italic>. MLPA analysis revealed deletion of four MLPA probes (IN8-2, EX9, EX10, and IN10). Sequence analysis of the breakpoint region in the patient revealed the exact position of the 63.1&#160;kb deletion (<bold>c</bold>)</p></caption><graphic position="anchor" xlink:href="439_2007_362_Fig4_HTML" id="MO4"/></fig>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
###xml 974 978 <span type="species:ncbi:10090">mice</span>
###xml 1078 1085 <span type="species:ncbi:9606">patient</span>
###xml 1318 1325 <span type="species:ncbi:9606">patient</span>
By long-range PCR amplification we obtained a deletion-spanning fragment of approximately3.5 kb from patient 2. Sequence analysis of this fragment revealed the 5' and 3' breakpoints, and a deletion size of 63.1 kb (Fig. 4). This genomic deletion predicts a 239 bp deletion in the transcript resulting in a shift of the open reading frame within the first predicted catalytic domain, coding for 29 alternative codons followed by a premature stop codon, which most likely results in non-sense-mediated decay of the transcript. Unfortunately no cell-line or tissue sample was available to test this hypothesis. Only the affected individual was homozygous for the deletion, the parents and five of the seven analyzed unaffected sibs were heterozygous carriers of the deletion. No significant match between the 5' and 3' junction sequences is present, therefore the LARGE deletion is likely the result of non-homologous end-joining as reported also for the Large deletion in myd mice (Browning et al. 2005). Fig. 4Schematic overview of LARGE exons 8-11 of wild-type sequence (a) and patient sequence (b), showing the exons depicted by black boxes and the MLPA probes depicted by black bars. MLPA analysis revealed deletion of four MLPA probes (IN8-2, EX9, EX10, and IN10). Sequence analysis of the breakpoint region in the patient revealed the exact position of the 63.1 kb deletion (c)
###end p 34
###begin p 35
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 121 132 121 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black boxes</italic>
###xml 165 175 165 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 370 371 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 69 76 <span type="species:ncbi:9606">patient</span>
###xml 309 316 <span type="species:ncbi:9606">patient</span>
Schematic overview of LARGE exons 8-11 of wild-type sequence (a) and patient sequence (b), showing the exons depicted by black boxes and the MLPA probes depicted by black bars. MLPA analysis revealed deletion of four MLPA probes (IN8-2, EX9, EX10, and IN10). Sequence analysis of the breakpoint region in the patient revealed the exact position of the 63.1 kb deletion (c)
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT1</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMT2</italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCMD</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FKRP</italic>
###xml 147 152 147 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2005b</xref>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large</italic>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2002</xref>
###xml 954 958 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2005</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1995</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2002</xref>
###xml 1035 1040 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 1495 1498 1491 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myd</italic>
###xml 1522 1526 1518 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2002</xref>
###xml 1543 1547 1539 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2003</xref>
###xml 1564 1568 1560 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2002</xref>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 223 230 <span type="species:ncbi:9606">patient</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
###xml 652 656 <span type="species:ncbi:10090">Mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 1029 1034 <span type="species:ncbi:9606">human</span>
###xml 1095 1102 <span type="species:ncbi:9606">patient</span>
###xml 1233 1240 <span type="species:ncbi:9606">patient</span>
###xml 1425 1432 <span type="species:ncbi:9606">patient</span>
###xml 1499 1503 <span type="species:ncbi:10090">mice</span>
We previously reported mutations in POMT1, POMT2, FCMD, and FKRP in approximately one-third of the WWS patients in our cohort (van Reeuwijk et al. 2005b). Here we report a homozygous 63-kb intragenic deletion in LARGE in a patient with WWS. The clinical features of the patients in this family do not diverge from the typical manifestations of other WWS patients. Hence, none of the five WWS genes that are known to date are associated with discriminating clinical features. The deletion described in this report is likely a loss of function mutation due to a predicted frameshift of the open reading frame within the first predicted catalytic domain. Mice carrying a similar disruptive defect in the Large gene display a severe muscle, eye, and brain phenotype, and have a shortened life span. With regard to the brain defects, these mice have severe neuronal migration defects resulting in a lissencephalic phenotype (Holzfeind et al. 2002; Lee et al. 2005; Mathews et al. 1995; Michele et al. 2002). The only previously known human LARGE mutations (p.E509K and p.C667fs) were identified in a patient with CMD, subtle structural brain abnormalities and severe mental retardation (MDC1D). The less severe clinical phenotype of this patient could be explained by residual activity of the LARGE protein. By an overlay assay, the authors demonstrated that residual alpha-dystroglycan present in a skeletal muscle biopsy in the patient retained laminin-binding, whereas this binding is lost in the myd mice (Holzfeind et al. 2002; Longman et al. 2003; Michele et al. 2002).
###end p 37
###begin p 38
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2002</xref>
###xml 226 231 226 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2005b</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2005</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2006</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">2006</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FKRP</italic>
###xml 664 669 664 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2005a</xref>
###xml 709 713 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCMD</italic>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">1998</xref>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCMD</italic>
###xml 909 913 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2003</xref>
###xml 948 955 948 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">POMGnT1</italic>
###xml 1035 1039 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2003</xref>
###xml 1056 1060 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
The existence of phenotypic variability for different mutations is also reported for other WWS genes. Mutations in the POMT1/2 genes were initially identified in WWS (Beltran-Valero de Bernabe et al. 2002; van Reeuwijk et al. 2005b), but subsequently also in milder conditions including limb-girdle muscular dystrophy subtype 2K (LGMD2K, MIM 609308) (Balci et al. 2005; Mercuri et al. 2006; van Reeuwijk et al. 2006). Conversely, FKRP mutations are a common cause of LGMD, denoted subtype LGMD2I, but rare mutations are also found in severe conditions such as MEB and WWS, two similar disorders with CMD and severe brain and eye malformations (van Reeuwijk et al. 2005a). A common hypomorphic mutation in the FCMD gene causes FCMD in the Japanese population (Kobayashi et al. 1998). However, loss-of-function FCMD mutations are found in more severe conditions, including WWS (Beltran-Valero de Bernabe et al. 2003). Finally, different mutations in POMGnT1 cause phenotypic variability within the MEB disease spectrum (Taniguchi et al. 2003; Yoshida et al. 2001).
###end p 38
###begin p 39
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2005</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2005</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2001</xref>
###xml 449 453 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2004</xref>
###xml 642 647 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 669 673 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2004</xref>
###xml 245 250 <span type="species:ncbi:9606">human</span>
LARGE is localized to the Golgi apparatus but the exact function of LARGE is unknown (Brockington et al. 2005; Grewal et al. 2005). It contains two putative catalytic domains, one related to a bacterial glycosyltransferase, and one related to a human glycosyltransferase (Grewal et al. 2001). In addition, LARGE interacts with the N-terminal domain of alpha-dystroglycan, which is essential for normal glycosylation of this protein (Kanagawa et al. 2004). Another remarkable finding is the therapeutic potential of LARGE, demonstrated by the recovery of dystroglycan processing and functioning in WWS/MEB fibroblasts by overexpression of the LARGE gene (Barresi et al. 2004).
###end p 39
###begin p 40
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large</italic>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2001</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2005</xref>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LARGE</italic>
###xml 273 281 <span type="species:ncbi:9606">patients</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 409 416 <span type="species:ncbi:9606">patient</span>
###xml 669 677 <span type="species:ncbi:9606">patients</span>
Our finding demonstrates the existence of phenotypic variability, especially with regard to the brain, caused by different mutations in LARGE. We identified a mutation in this gene in 1 of 30 families, indicating that this gene is causal for only a small percentage of WWS patients. However, two spontaneous mouse mutants for Large, both due to intragenic deletions, have been reported in addition to the WWS patient described here (Grewal et al. 2001; Lee et al. 2005). The genomic size of LARGE may predispose this gene for genomic deletions. To exclude LARGE from genetic involvement in LGMD, or CMD with or without brain involvement it will be important to examine patients for genomic deletions in this gene.
###end p 40
###begin title 41
Electronic supplementary material
###end title 41
###begin p 42
Below is the link to the electronic supplementary material.
###end p 42
###begin p 43
40 kb
###end p 43
###begin p 44
We thank the families for contributing material for this study. This work was supported by grants from the 'Prinses Beatrix Fonds' and 'Stichting Spieren voor Spieren' (MAR02-226), and the 'Hersenstichting Nederland' (11F503.21). JEH thanks John Armour and Jess Tyson for advice on MAPH. JEH is a BBSRC Research Development Fellow. Funding from MDA USA, The Wellcome Trust and The BBSRC to JEH.
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Measurement of locus copy number by hybridisation with amplifiable probes
###end article-title 46
###begin article-title 47
An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene
###end article-title 47
###begin article-title 48
###xml 51 56 <span type="species:ncbi:9606">human</span>
Dystroglycan: from biosynthesis to pathogenesis of human disease
###end article-title 48
###begin article-title 49
LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies
###end article-title 49
###begin article-title 50
A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype
###end article-title 50
###begin article-title 51
Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy
###end article-title 51
###begin article-title 52
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
A rapid PCR method for genotyping the Large(myd) mouse, a model of glycosylation-deficient congenital muscular dystrophy
###end article-title 52
###begin article-title 53
###xml 23 28 <span type="species:ncbi:9606">human</span>
Genetic defects in the human glycome
###end article-title 53
###begin article-title 54
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse
###end article-title 54
###begin article-title 55
Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies
###end article-title 55
###begin article-title 56
###xml 29 34 <span type="species:ncbi:9606">human</span>
High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH)
###end article-title 56
###begin article-title 57
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders
###end article-title 57
###begin article-title 58
Molecular recognition by LARGE is essential for expression of functional dystroglycan
###end article-title 58
###begin article-title 59
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
###end article-title 59
###begin article-title 60
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases
###end article-title 60
###begin article-title 61
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan
###end article-title 61
###begin article-title 62
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Phenotypic and pathologic evaluation of the myd mouse. A candidate model for facioscapulohumeral dystrophy
###end article-title 62
###begin article-title 63
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
###end article-title 63
###begin article-title 64
Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease
###end article-title 64
###begin article-title 65
Glyc-O-genetics of Walker-Warburg syndrome
###end article-title 65
###begin article-title 66
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome
###end article-title 66
###begin article-title 67
The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation
###end article-title 67
###begin article-title 68
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1
###end article-title 68
###begin p 69
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 69
###begin p 70
The online version of this article (doi:10.1007/s00439-007-0362-y) contains supplementary material, which is available to authorized users.
###end p 70

